ASTH
Undervalued by 257.1% based on the discounted cash flow analysis.
Market cap | $2.94 Billion |
---|---|
Enterprise Value | $2.84 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $1.3 |
Beta | 1.22 |
Outstanding Shares | 47,615,096 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 41.68 |
---|---|
PEG | -75.93 |
Price to Sales | 0.53 |
Price to Book Ratio | 24.79 |
Enterprise Value to Revenue | 1.26 |
Enterprise Value to EBIT | 35.8 |
Enterprise Value to Net Income | 81 |
Total Debt to Enterprise | 0.02 |
Debt to Equity | 0.96 |
No data
No data
apollo medical holdings, inc., a physician-centric technology-powered healthcare management company, provides medical care services. the company, leveraging its proprietary population health management and healthcare delivery platform, o...